Want to see IN:SHIVALIK full AI Analyst Report?

Shivalik Rasayan Ltd (SHIVALIK) Price & Analysis

0 Followers

SHIVALIK Stock Chart & Stats

₹358.75

-₹13.65(-1.86%)

At close: Jan 08 4:00 PM EST

₹358.75

-₹13.65(-1.86%)

Day’s Range― - ―

52-Week Range₹206.00 - ₹532.50

Previous CloseN/A

Volume18.40K

Average Volume (3M)1.25K

Market Cap

₹4.23B

Enterprise Value₹7.35K

Total Cash (Recent Filing)₹343.68M

Total Debt (Recent Filing)₹1.14B

Price to Earnings (P/E)34.5

Beta0.81

Next Earnings

Aug 14, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.19%

Share Statistics

EPS (TTM)7.55

Shares Outstanding15,750,365

10 Day Avg. Volume987

30 Day Avg. Volume1,247

Financial Highlights & Ratios

PEG Ratio-1.05

Price to Book (P/B)0.58

Price to Sales (P/S)0.94

P/FCF Ratio-5.96

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Steady Revenue Growth And Resilient DemandSustained top-line growth over multiple years signals durable end-market demand and supports capacity utilization. For a B2B specialty chemical maker this provides a predictable revenue base to absorb cyclical swings, justify incremental investment, and eventually restore margins if cost control improves.

Conservative Balance Sheet With Low LeverageLow debt relative to equity gives the company structural financial flexibility to fund working capital, capex, or weather cash-flow shortfalls without immediate refinancing pressure. This reduces solvency risk and preserves options to invest in specialty capacity or customer qualifications over the medium term.

Specialty Chemicals B2B Business Model And Customer FocusA focus on specialty intermediates sold to pharma and agrochemical customers creates structural customer stickiness and pricing resilience versus pure commodities. Customer-specific supplies and B2B bulk contracts support repeat volumes and differentiation, sustaining higher-margin product mix potential over time.

Bears Say

Persistent Negative Operating And Free Cash FlowChronic negative operating and free cash flows indicate structural cash-conversion problems, likely from working-capital strain or margin pressure. That forces reliance on reserves or financing to run operations and capex, limiting ability to self-fund growth, pay down debt, or return cash to shareholders.

Weakened Profitability And Margin CompressionDeclining margins reduce the conversion of revenue into sustainable earnings and cash flow. If driven by competitive pressure, input-cost inflation, or adverse product mix, margin weakness can persist and impede ROE recovery, constraining reinvestment and shareholder returns absent strategic margin remediation.

Declining Return On Equity And Capital EfficiencyLow single-digit ROE reflects poor capital efficiency and suggests incremental assets or equity are not generating commensurate profits. Persistently low ROE can signal the need for restructuring product mix, pricing, or capital allocation to restore long-term shareholder value.

Shivalik Rasayan Ltd News

Shivalik Rasayan Publishes Audited Results for Quarter and Year Ended March 31, 2026

An announcement from Shivalik Rasayan Ltd ( ($IN:SHIVALIK) ) is now available. Shivalik Rasayan Limited announced that its...

3M ago

Shivalik Rasayan Limited Publishes Regulatory Advertisements

The latest update is out from Shivalik Rasayan Ltd ( ($IN:SHIVALIK) ). Shivalik Rasayan Limited announced the publication...

10M ago

SHIVALIK FAQ

What was Shivalik Rasayan Ltd’s price range in the past 12 months?

Shivalik Rasayan Ltd lowest stock price was ₹206.00 and its highest was ₹532.50 in the past 12 months.

What is Shivalik Rasayan Ltd’s market cap?

Shivalik Rasayan Ltd’s market cap is ₹4.23B.

When is Shivalik Rasayan Ltd’s upcoming earnings report date?

Shivalik Rasayan Ltd’s upcoming earnings report date is Aug 14, 2026 which is today.

How were Shivalik Rasayan Ltd’s earnings last quarter?

Shivalik Rasayan Ltd released its earnings results on May 27, 2026. The company reported ₹2.87 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Shivalik Rasayan Ltd overvalued?

According to Wall Street analysts Shivalik Rasayan Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Shivalik Rasayan Ltd pay dividends?

Shivalik Rasayan Ltd pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.19%. See more information on Shivalik Rasayan Ltd dividends here

What is Shivalik Rasayan Ltd’s EPS estimate?

Shivalik Rasayan Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Shivalik Rasayan Ltd have?

Shivalik Rasayan Ltd has 15,750,365 shares outstanding.

What happened to Shivalik Rasayan Ltd’s price movement after its last earnings report?

Shivalik Rasayan Ltd reported an EPS of ₹2.87 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.956%.

Which hedge fund is a major shareholder of Shivalik Rasayan Ltd?

Currently, no hedge funds are holding shares in IN:SHIVALIK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Shivalik Rasayan Ltd

Established on March 16, 1979, by Rahul Bishnoi, Shivalik Rasayan Limited is an Indian firm specializing in the creation of pharmaceutical and agrochemical products. Based in New Delhi, its offerings notably feature organophosphorous-based insecticides and various other chemicals.